Shilpa Medicare Ltd share price logo

Shilpa Medicare Share Price

(SHILPAMED)

Check the latest share price of Shilpa Medicare, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹669.32.85%

as on 02:15PM, 13 May 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Shilpa Medicare Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹650.8
    Day's Price Range
    ₹684.4
  • 52 Week's Low

    52 Week's High

    ₹417.6
    52-Week Price Range
    ₹959.5
1 Month Return-0.75 %
3 Month Return-4.3 %
1 Year Return+ 30.44 %
3 Year Return+ 68.54 %
5 Year Return+ 76.95 %
Previous Close₹650.75
Open₹669.70
Volume1.73L
Upper Circuit₹780.90
Lower Circuit₹520.60

Shilpa Medicare Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹6,363.74 Cr

Return on Equity (ROE)

1.59

PE Ratio (TTM)

69.52

Return on capital employed (ROCE)

2.77

Industry PE ratio

53.64

Beta (LTM)

1.27

P/B Ratio

1.87

Dividend Yield

0

PEG Ratio

7.37

Quarterly Earnings Growth YOY

576.17

EPS (TTM)

3.68

Sector

Pharmaceuticals

Book Value

208.37

Technical Analysis

How to invest in Shilpa Medicare

Investing in Shilpa Medicare is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Shilpa Medicare or SHILPAMED on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Shilpa Medicare or start an SIP based on the market price on each investment date.

You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Shilpa Medicare with just a few clicks!

Shilpa Medicare Stock's Interest Amongst Investors

-22%

Period May 13, 2025 to Apr 13, 2025. Change in 30 Days vs previous period

Search interest for Shilpa Medicare Ltd Stock has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Shilpa Medicare Valuation

Track how the P/E of Shilpa Medicare has moved over time to understand valuation trends.

Shilpa Medicare in the last 5 years

  • Overview

  • Trends

Lowest (-6579.29x)

March 28, 2024

Industry (53.64x)

May 12, 2025

Today (69.52x)

May 12, 2025

Highest (503.73x)

February 21, 2023

LowHigh

Today’s Price to Earnings Ratio: 69.52x

Analysts Recommendation on Shilpa Medicare

Get updated buy, sell, and hold recommendations by analysts on Shilpa Medicare.

based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

100% of analysts recommend a 'BUY' rating for Shilpa Medicare. Average target price of ₹1191

Source: S&P Global Market Intelligence

Analysts Forecast on Shilpa Medicare

Get share price movements and forecasts by analysts on Shilpa Medicare.

Shilpa Medicare price forecast by 2 analysts

Upside of83.02%

High

₹1525

Target

₹1191.00

Low

₹857

Shilpa Medicare target price ₹1191, a slight upside of 83.02% compared to current price of ₹669.3. According to 2 analysts rating.

Source: S&P Global Market Intelligence

Shilpa Medicare Financials

Get the annual and quarterly financial summary of Shilpa Medicare, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue

(in ₹ Cr)

287 (0%)292 (2%)293 (0%)344 (18%)319 (7%)
Net Income

(in ₹ Cr)

5 (0%)24 (421%)14 (43%)18 (28%)32 (77%)
Net Profit Margin1.64% (0%)8.40% (412%)4.81% (43%)5.22% (9%)9.95% (91%)
Value in ₹ crore
Details2021202220232024
Total Assets

(in ₹ Cr)

2555 (0%)2966 (16%)2597 (12%)2501 (4%)
Total Liabilities

(in ₹ Cr)

917 (0%)900 (2%)480 (47%)359 (25%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow

(in ₹ Cr)

130 (0%)70 (46%)174 (150%)2 (99%)8 (286%)

Shilpa Medicare Index Inclusions

BSE Healthcare

₹41,923.85

0.78 (324.56%)

BSE Small-Cap

₹49,065.60

0.76 (371.85%)

Shilpa Medicare Earnings and Dividends

View detailed summary of the earnings and dividend history of Shilpa Medicare.

  • Shilpa Medicare Ltd Earnings Results

    Shilpa Medicare Ltd’s net profit jumped 593.89% since last year same period to ₹31.78Cr in the Q3 2024-2025. On a quarterly growth basis, Shilpa Medicare Ltd has generated 77.15% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Shilpa Medicare Ltd Dividends May,2022

    In the quarter ending March 2022, Shilpa Medicare Ltd has declared dividend of ₹1.10 - translating a dividend yield of 0.34%.

    Read More about Dividends

Shilpa Medicare Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Shilpa Medicare.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
44.23%
0.00
Foreign Institutions
10.97%
0.00
Mutual Funds
4.05%
0.00
Retail Investors
37.25%
0.00
Others
3.5%
0.00

Shilpa Medicare vs Peers

Compare market cap, revenue, PE, and other key metrics of Shilpa Medicare with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY6,363.7415.39%0.53311,151
BUY27,067.89109.92%0.523001,051
BUY14,004.8627.28%0.57726,702
NA4,823.362.39%0.79-38875
BUY13,733.8540.08%0.682181,296

Shilpa Medicare News & Key Events

Latest news and events at one place to help you take investing decisions in Shilpa Medicare.

  • Shilpa Medicare Secures EMA GMP Certification - 06 May, 2025

    Shilpa Medicare's Unit VI in Bengaluru has received Good Manufacturing Practice (GMP) approval from the European Medicines Agency, enhancing its ability to market innovative drug delivery systems in the EU.
  • Shilpa Medicare Secures EU GMP Certification - 05 May, 2025

    Shilpa Medicare's subsidiary, Shilpa Biologics, has obtained European GMP certification for its Dharwad plant, allowing the production of test batches following a successful inspection by Austrian authorities.
  • Shilpa Medicare Settles Arbitration with Celltrion - 17 Apr, 2025

    Shilpa Medicare has settled its arbitration dispute with Celltrion for $3.4 million, resolving a previous award of approximately $3.7 million. The settlement will be paid in installments by July 2025 and will not affect future operations.
  • Shilpa Medicare Secures USFDA Approval for Varenicline - 09 Apr, 2025

    Shilpa Medicare has received USFDA approval for its Varenicline tablets, a generic version of Chantix, targeting the $203 million U.S. smoking cessation market. This approval enhances Shilpa's position in the pharmaceutical sector.

Insights on Shilpa Medicare Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 9.90% to 10.97% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, SHILPAMED stock has moved up by 30.4%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 14.06 Cr → 31.78 Cr (in ₹), with an average increase of 32.6% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 44.23% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 51.9% return, outperforming this stock by 21.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 150.7% return, outperforming this stock by 82.2%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 348.79 Cr → 320.79 Cr (in ₹), with an average decrease of 8.0% per quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 4.89% to 4.05% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 37.60% to 37.25% in Mar 2025 quarter

About Shilpa Medicare

Shilpa Medicare Limited (SML) was established in 1987 and converted to a public limited company in 1993. They are one of the leading API and formulations manufacturers, with expertise in oncology and non-oncology medicines, with over 44 APIs and 16 injectable dosage forms and 19 oral solid dosage forms. SML deploy sophisticated technology in order to comply with international standards. In 2015, funds were raised by allotting 1.76 Mn equity shares at Rs. 423/ share, and in 2016, the face value of equity shares was split into two equity shares of Rs.1/ each. Raichem Medicare Pvt. Ltd., a subsidiary of SML successfully installed all machinery and recruited personnel. During FY16, they launched generic versions of Vidaza Injection and Xeloda Tablets. In 2017, Navya Biologicals Private Limited was acquired and in 2019, they invested Rs 22.71 cr in Shilpa Therapeutics Pvt. Ltd and disinvested 24% stake in Raichem Medicare Pvt. Ltd. In 2021, they launched a pediatric dose paracetamol oral thin film, Molshil and acquired stake in FTF Pharma Pvt. Ltd, Koanaa Healthcare Canada, etc. In 2022, they approved Slump sale of Active Pharmaceutical Ingredient API Business to Shilpa Pharma Lifesciences Limited.

Revenue: ₹319.32Cr as on December 2024 (Q4 24)
Net Profit: ₹31.78Cr as on December 2024 (Q4 24)
Listing date: 03 Dec, 2009
Chairperson Name: Omprakash Inani
OrganisationShilpa Medicare Ltd
IndustryPharmaceuticals
CEOOmprakash Inani
E-voting on sharesClick here to vote

FAQs

What is Shilpa Medicare Ltd price today?

Shilpa Medicare Ltd share price today stands at ₹669.3, Open: ₹669.7, Previous Close: ₹650.75, High: ₹684.4, Low: ₹650.8, 52 Week High: ₹959.5, 52 Week Low: ₹417.6.

How to Buy Shilpa Medicare Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Shilpa Medicare Ltd shares

What are today's traded volumes of Shilpa Medicare Ltd?

Today's traded volume of Shilpa Medicare Ltd(SHILPAMED) is 1.73L.

What is today's market capitalisation of Shilpa Medicare Ltd?

Today's market capitalisation of Shilpa Medicare Ltd(SHILPAMED) is ₹6,363.74 Cr.

What is the 52 Week High and Low Range of Shilpa Medicare Ltd?

Shilpa Medicare Ltd (SHILPAMED)
Price
52 Week High
₹959.5
52 Week Low
₹417.6

How much percentage Shilpa Medicare Ltd is down from its 52 Week High?

Shilpa Medicare Ltd (SHILPAMED) share price is ₹669.3. It is down -30.24% from its 52 Week High price of ₹959.5

How much percentage Shilpa Medicare Ltd is up from its 52 Week low?

Shilpa Medicare Ltd (SHILPAMED) share price is ₹669.3. It is up 60.27% from its 52 Week Low price of ₹417.6